Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2730388
Reference Type
Journal Article
Title
Comparative study of the efficacy and tolerability of amlodipine and lisinopril in the treatment of essential hypertension
Author(s)
Franchi, M; Di Perri, T
Year
1997
Is Peer Reviewed?
Yes
Journal
Clinical Drug Investigation
ISSN:
1173-2563
Report Number
IPA/98/1154092
Volume
Drug Invest
Issue
REF 13
Language
English
Abstract
IPA COPYRIGHT: ASHP An open, randomized, crossover study was conducted for 3 months to assess the efficacy and tolerability of 5-10 mg/day of amlodipine vs 10-20 mg/day of lisinopril in 20 patients, mean age 59 yr, with mild to moderate essential hypertension. Both drugs significantly reduced systolic and diastolic blood pressures compared with baseline, although the reduction observed with amlodipine was significantly greater than that observed with lisinopril (23.5 vs 16.5 mm Hg for sitting systolic blood pressure; 21.1 vs 13.8 mm Hg for sitting diastolic pressure). Thirty-five percent of patients treated with the lower dosage of amlodipine (5 mg/day) experienced adequate blood pressure control, whereas only 10% could be successfully controlled with the initial dosage of lisinopril (10 mg/day). All patients were successfully controlled with higher dosages. The findings suggested that amlodipine provides effective control of blood pressure in patients with mild to moderate hypertension.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity